Cargando…
Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857087/ https://www.ncbi.nlm.nih.gov/pubmed/34940960 http://dx.doi.org/10.1007/s40264-021-01130-7 |
| _version_ | 1784653968265183232 |
|---|---|
| author | Day, John W. Mendell, Jerry R. Mercuri, Eugenio Finkel, Richard S. Strauss, Kevin A. Kleyn, Aaron Tauscher-Wisniewski, Sitra Tukov, Francis Fonyuy Reyna, Sandra P. Chand, Deepa H. |
| author_facet | Day, John W. Mendell, Jerry R. Mercuri, Eugenio Finkel, Richard S. Strauss, Kevin A. Kleyn, Aaron Tauscher-Wisniewski, Sitra Tukov, Francis Fonyuy Reyna, Sandra P. Chand, Deepa H. |
| author_sort | Day, John W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8857087 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88570872022-02-23 Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy Day, John W. Mendell, Jerry R. Mercuri, Eugenio Finkel, Richard S. Strauss, Kevin A. Kleyn, Aaron Tauscher-Wisniewski, Sitra Tukov, Francis Fonyuy Reyna, Sandra P. Chand, Deepa H. Drug Saf Correction Springer International Publishing 2021-12-23 2022 /pmc/articles/PMC8857087/ /pubmed/34940960 http://dx.doi.org/10.1007/s40264-021-01130-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Day, John W. Mendell, Jerry R. Mercuri, Eugenio Finkel, Richard S. Strauss, Kevin A. Kleyn, Aaron Tauscher-Wisniewski, Sitra Tukov, Francis Fonyuy Reyna, Sandra P. Chand, Deepa H. Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title | Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title_full | Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title_fullStr | Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title_full_unstemmed | Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title_short | Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy |
| title_sort | correction to: clinical trial and postmarketing safety of onasemnogene abeparvovec therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857087/ https://www.ncbi.nlm.nih.gov/pubmed/34940960 http://dx.doi.org/10.1007/s40264-021-01130-7 |
| work_keys_str_mv | AT dayjohnw correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT mendelljerryr correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT mercurieugenio correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT finkelrichards correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT strausskevina correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT kleynaaron correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT tauscherwisniewskisitra correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT tukovfrancisfonyuy correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT reynasandrap correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy AT chanddeepah correctiontoclinicaltrialandpostmarketingsafetyofonasemnogeneabeparvovectherapy |